Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg - Contacts and Locations

Home

Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg

This study has been completed.

Study NCT00649558. Last updated on March 31, 2008. Information provided by Mylan Pharmaceuticals

Please refer to this study by its ClinicalTrials.gov identifier: NCT00649558

Locations


United States, North Dakota
	PRACS Institute, Ltd.
	Fargo, North Dakota, United States, 58104

Sponsors and Collaborators

Mylan Pharmaceuticals

Investigators


Principal Investigator:	James D Carlson, Pharm. D.	PRACS Institute Ltd.